About | Support Us | Contact
Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.
Home Page > Investigator Page

Francis Szoka, Ph.D.

University of California, San Francisco # of Grants: 3

Grants
Gene therapy for emphysema 1997 (Cycle 6) $443,179
Pulmonary Disease Research Project Awards
Gene Therapy for Emphysema 1994 (Cycle 3) $74,844
Pulmonary Disease Inno Dev & Exp Awards (IDEAS)
Liposome targeted chemotherapy to treat lung cancer 1999 (Cycle 8) $75,000
Pulmonary Disease Inno Dev & Exp Awards (IDEAS)
Publications
Effects of complement on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes
Periodical: Human Gene Therapy Index Medicus:
Authors: Barron LG, Meyer KB, Szoka FC Jr ART
Yr: 1998 Vol: 9 Nbr: Abs: Pg: 315-323
Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery
Periodical: Journal of Medicinal Chemistry Index Medicus:
Authors: Wang J, Guo X, Xu Y, Barron L, Szoka FC Jr ART
Yr: 1998 Vol: 41 Nbr: Abs: Pg: 2207-2215
Biochemical, morphological and functional analysis of a cyclic peptide, phospholipid and DNA tenary complex used for gene therapy
Periodical: Journal of Liposome Research Index Medicus:
Authors: Legendre JY, Huang S-K, Szoka FC Jr ART
Yr: 1998 Vol: 8 Nbr: Abs: Pg: 347-366
Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes
Periodical: Human Gene Therapy Index Medicus:
Authors: Plank C, Tang MX, Wolfe AR, Szoka FC Jr. ART
Yr: 1999 Vol: 10 Nbr: Abs: Pg: 319-332
Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
Periodical: Human Gene Therapy Index Medicus:
Authors: Barron LG, Uyechi LS, Szoka FC Jr. ART
Yr: 1999 Vol: 6 Nbr: Abs: Pg: 1179-1183
Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration
Periodical: Human Gene Therapy Index Medicus:
Authors: Barron LG, Gagne L, Szoka FC Jr. ART
Yr: 1999 Vol: 10 Nbr: Abs: Pg: 1683-1894
Physicochemical characterization and purification of cationic lipoplexes
Periodical: Biophysical Journal Index Medicus:
Authors: Xu Y,Hui S-W, Frederik P, Szoka FC ART
Yr: 1999 Vol: 77 Nbr: Abs: Pg: 341-353
Controlled template-assisted assembly of plasmid DNA into nanometric particles with high DNA concentration
Periodical: Bioconjugate Chemistry Index Medicus:
Authors: Ouyang M, Remy J-S, Szoka FC ART
Yr: 2000 Vol: 11 Nbr: 1 Abs: Pg: 104-112
Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components
Periodical: Human Gene Therapy Index Medicus:
Authors: Uyechi LS, Thurston G, Gagne L, Szoka Jr FC ART
Yr: 2001 Vol: 8 Nbr: Abs: Pg: 828-836
Effects of complement on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes
Periodical: Human Gene Therapy Index Medicus:
Authors: Barron LG, Meyer KB, Szoka FC Jr ART
Yr: 1998 Vol: 9 Nbr: Abs: Pg: 315-323
Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery
Periodical: Journal of Medicinal Chemistry Index Medicus:
Authors: Wang J, Guo X, Xu Y, Barron L, Szoka FC Jr ART
Yr: 1998 Vol: 41 Nbr: Abs: Pg: 2207-2215
Biochemical, morphological and functional analysis of a cyclic peptide, phospholipid and DNA tenary complex used for gene therapy
Periodical: Journal of Liposome Research Index Medicus:
Authors: Legendre JY, Huang S-K, Szoka FC Jr ART
Yr: 1998 Vol: 8 Nbr: Abs: Pg: 347-366
Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes
Periodical: Human Gene Therapy Index Medicus:
Authors: Plank C, Tang MX, Wolfe AR, Szoka FC Jr. ART
Yr: 1999 Vol: 10 Nbr: Abs: Pg: 319-332
Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
Periodical: Human Gene Therapy Index Medicus:
Authors: Barron LG, Uyechi LS, Szoka FC Jr. ART
Yr: 1999 Vol: 6 Nbr: Abs: Pg: 1179-1183
Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration
Periodical: Human Gene Therapy Index Medicus:
Authors: Barron LG, Gagne L, Szoka FC Jr. ART
Yr: 1999 Vol: 10 Nbr: Abs: Pg: 1683-1894
Physicochemical characterization and purification of cationic lipoplexes
Periodical: Biophysical Journal Index Medicus:
Authors: Xu Y,Hui S-W, Frederik P, Szoka FC ART
Yr: 1999 Vol: 77 Nbr: Abs: Pg: 341-353
Controlled template-assisted assembly of plasmid DNA into nanometric particles with high DNA concentration
Periodical: Bioconjugate Chemistry Index Medicus:
Authors: Ouyang M, Remy J-S, Szoka FC ART
Yr: 2000 Vol: 11 Nbr: 1 Abs: Pg: 104-112
Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components
Periodical: Human Gene Therapy Index Medicus:
Authors: Uyechi LS, Thurston G, Gagne L, Szoka Jr FC ART
Yr: 2001 Vol: 8 Nbr: Abs: Pg: 828-836
Liposome encapsulated doxorubicin targeted to CD44: A strategy to kill CD44 overexpressing tumor cells
Periodical: Cancer Research Index Medicus:
Authors: Eliaz RE, Szoka Jr FC ART
Yr: 2001 Vol: 61 Nbr: Abs: Pg: 2592-2601
Liposome encapsulated doxorubicin targeted to CD44: A strategy to kill CD44 overexpressing tumor cells
Periodical: Cancer Research Index Medicus:
Authors: Eliaz RE, Szoka Jr FC ART
Yr: 2001 Vol: 61 Nbr: Abs: Pg: 2592-2601